UBS Group AG - MOLECULIN BIOTECH INC ownership

Back to all holdings Add to watchlist

MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D200. A total of 28 filers reported holding MOLECULIN BIOTECH INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
UBS Group AG ownership history of MOLECULIN BIOTECH INC
ValueSharesWeighting
Q3 2023$85
-99.3%
200
-98.2%
0.00%–
Q4 2022$11,918
+8.3%
11,243
+7.7%
0.00%–
Q3 2022$11,000
+450.0%
10,444
+531.8%
0.00%–
Q2 2022$2,000
-50.0%
1,653
+17.8%
0.00%–
Q3 2021$4,0000.0%1,403
+31.0%
0.00%–
Q2 2021$4,000–1,071–0.00%–
 Download
Other shareholders
MOLECULIN BIOTECH INC shareholders Q3 2022
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,036,853$1,099,0640.41%
JMAC ENTERPRISES LLC 13,132$13,9200.00%
Virtu Financial LLC 13,791$150.00%
Sigma Planning Corp 57,500$60,9500.00%
VANGUARD GROUP INC 1,080,122$1,144,9300.00%
UBS Group AG 11,243$11,9180.00%
MASSMUTUAL TRUST CO FSB/ADV 167$00.00%
OSAIC HOLDINGS, INC. 968$1,3540.00%
FMR LLC 2$20.00%
BANK OF AMERICA CORP /DE/ 6,683$7,0840.00%
View complete list of MOLECULIN BIOTECH INC shareholders